Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New methods of pathogenic bacteria elimination.

Krystyna I Wolska1, Anna Kraczkiewicz-Dowjat, Anna M Grudniak

  • 1Department of Bacterial Genetics, Institute of Microbiology, University of Warsaw, 02-096 Warsaw, Poland.

Polish Journal of Microbiology
|March 25, 2005
PubMed
Summary

New strategies combat antibiotic resistance using engineered plasmids for pathogen elimination. These methods involve plasmid transfer, run-away replication, or bacteriocin activity, but require strict safety measures for live donor bacteria.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interrelationships between Peak Strain Dispersion, Myocardial Work Indices, Isovolumetric Relaxation and Systolic-Diastolic Coupling in Middle-Aged Healthy Subjects.

Journal of clinical medicine·2023
Same author

<i>In vitro</i> activity of ceftobiprole and comparator antibiotics against contemporary European isolates (2016-19).

JAC-antimicrobial resistance·2022
Same author

No Evidence for Ceftobiprole-Induced Immune Hemolytic Anemia in Three Phase 3 Clinical Trials.

Infection and drug resistance·2020
Same author

In vitro susceptibility testing of ceftobiprole against 880 European respiratory tract infection isolates of methicillin-resistant Staphylococcus aureus followed by whole genome sequencing of ceftobiprole-resistant isolates.

Diagnostic microbiology and infectious disease·2020
Same author

Interlaboratory Analysis of Isavuconazole Plasma Concentration Assays Among European Laboratories.

Therapeutic drug monitoring·2019
Same author

Foamy Virus Vectors Transduce Visceral Organs and Hippocampal Structures following In Vivo Delivery to Neonatal Mice.

Molecular therapy. Nucleic acids·2018

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biotechnology

Background:

  • Antibiotic resistance is a growing global health threat, necessitating novel pathogen elimination strategies.
  • Current strategies include using engineered plasmids for targeted bacterial killing.

Purpose of the Study:

  • To explore the use of conjugative transfer of recombinant plasmids as a novel strategy for eliminating pathogenic bacteria.
  • To investigate plasmid-mediated mechanisms like run-away replication and bacteriocin activity for pathogen eradication.

Main Methods:

  • Utilizing live bacteria as donors for plasmid vectors encoding killing determinants.
  • Implementing conjugative transfer of recombinant plasmids into target pathogenic bacteria.
  • Employing plasmid run-away replication and bacteriocin production for bacterial elimination.

Related Experiment Videos

Main Results:

  • Engineered plasmids can be conjugatively transferred to eliminate pathogenic recipients.
  • Plasmid-encoded bacteriocins and run-away replication are effective killing mechanisms.
  • Live donor bacteria necessitate stringent safety protocols to mitigate biohazard risks.

Conclusions:

  • Conjugative transfer of engineered plasmids offers a promising avenue for combating antibiotic-resistant pathogens.
  • Careful consideration of safety measures is crucial when using live bacteria as plasmid donors.